Magnetic albumin immuno nanospheres as an efficient gene delivery system for a potential use in lung cancer: preparation, in vitro targeting and biological effect analysis
Abstract Magnetic albumin immuno nanospheres (MAINs) simultaneously loaded with super paramagnetic iron oxide nanoparticles for targeting application and anticancer gene, plasmid survivin/shRNA (pshRNA) and modified with anti EGFR monoclonal antibody Cetuximab for targeting and treatment agents, were prepared for targeting lung cancer. Transmission electron microscopy images and transfection photographs, respectively, showed that magnetic nanoparticles and pshRNA were successfully encased in the albumin nanospheres. The release profiles in vitro indicated that nanospheres had an obvious effect of sustained release of pshRNA. The results of slide agglutination test and immunofluorescence analysis demonstrated that the immuno nanospheres retained the immuno reactivity of Cetuximab. The MAINs significantly increased adherence and uptake by GLC 82 lung cancer cells over expressed epidermal growth factor receptor over a magnetic albumin nanospheres (MANs) control. The pshRNA loaded MAINs formulation was more effective than equimolar doses of free Cetuximab, single magnetic targeting with pshRNA (pshRNA loaded MANs) or single monoclonal antibody targeting with pshRNA (pshRNA loaded AINs) in the treatment of GLC 82 lung cancer cells. Collectively, the study indicates that the novel pshRNA loaded magnetic immuno nanospheres represent a promising approach for magnetic and monoclonal antibody dependent gene targeting in lung cancer therapy.
Journal of drug targeting